Antigliadin and antiendomysium antibody determination for coeliac disease.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMC 1793455)

Published in Arch Dis Child on August 01, 1991

Authors

A Bürgin-Wolff1, H Gaze, F Hadziselimovic, H Huber, M J Lentze, D Nusslé, C Reymond-Berthet

Author Affiliations

1: Department of Microbiology and Immunology, University Children's Hospital, Basel, Switzerland.

Articles citing this

The Oslo definitions for coeliac disease and related terms. Gut (2012) 5.76

ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol (2013) 4.36

Effectiveness of antigliadin antibodies as a screening test for celiac disease in children. CMAJ (1997) 1.59

Symptoms and signs in individuals with serology positive for celiac disease but normal mucosa. BMC Gastroenterol (2009) 1.39

Intestinal biopsy is not always required to diagnose celiac disease: a retrospective analysis of combined antibody tests. BMC Gastroenterol (2013) 1.19

Endomysial antibody in the diagnosis and management of coeliac disease. Postgrad Med J (2000) 1.11

Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up. Dig Dis Sci (2008) 1.08

Clinical presentation of celiac disease and the diagnostic accuracy of serologic markers in children. Eur J Pediatr (2008) 1.00

The role of antitissue transglutaminase assay for the diagnosis and monitoring of coeliac disease: a French-Italian multicentre study. J Clin Pathol (2003) 0.99

Lymphocytic gastritis and associated small bowel disease: a diffuse lymphocytic gastroenteropathy? J Clin Pathol (1995) 0.97

Coeliac disease and oats: a systematic review. Postgrad Med J (2006) 0.96

Performance of serology assays for diagnosing celiac disease in a clinical setting. Clin Vaccine Immunol (2009) 0.95

Twenty years of childhood coeliac disease in The Netherlands: a rapidly increasing incidence? Gut (1997) 0.93

Screening for celiac disease in the general population and in high-risk groups. United European Gastroenterol J (2015) 0.91

Influence of infant feeding and gluten intake on coeliac disease. Arch Dis Child (1997) 0.89

Anti-alpha-gliadin antibodies (AGA) in the serum of coeliac children and controls recognize an identical collection of linear epitopes of alpha-gliadin. Clin Exp Immunol (1998) 0.89

Genetic difference in HLA-DR phenotypes between coeliac disease and transitory gluten intolerance. Arch Dis Child (1995) 0.88

Screening for coeliac disease: the meaning of low titers of anti-gliadin antibodies (AGA) in non-coeliac children. Eur J Epidemiol (1997) 0.83

Children with celiac disease and high tTGA are genetically and phenotypically different. World J Gastroenterol (2013) 0.82

Positive deamidated gliadin peptide antibodies and negative tissue transglutaminase IgA antibodies in a pediatric population: to biopsy or not to biopsy. Clin Vaccine Immunol (2010) 0.81

Dermatomyositis associated with celiac disease: response to a gluten-free diet. Can J Gastroenterol (2006) 0.80

Is the sugar intestinal permeability test a reliable investigation for coeliac disease screening? Gut (1997) 0.79

Salivary IgA antigliadin antibody as a marker for coeliac disease. Arch Dis Child (1992) 0.78

Screening tests for coeliac disease. Arch Dis Child (1995) 0.78

The clinical response to gluten challenge: a review of the literature. Nutrients (2013) 0.77

Clinical application of immunological markers as monitoring tests in celiac disease. Dig Dis Sci (1999) 0.76

Screening for celiac disease in Down's syndrome patients revealed cases of subtotal villous atrophy without typical for celiac disease HLA-DQ and tissue transglutaminase antibodies. World J Gastroenterol (2006) 0.76

Transient gluten intolerance. Arch Dis Child (1992) 0.75

Enzyme linked immuno-spot; a useful tool in the search for elusive immune markers in common pediatric immunological diseases. Cells (2012) 0.75

Celiac disease screening assays for children younger than 3 years of age: the performance of three serological tests. Dig Dis Sci (2011) 0.75

Articles cited by this

Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. Nature (1989) 4.72

Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics (1983) 4.51

IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease. Br J Dermatol (1984) 2.95

Uniparental paternal disomy in Angelman's syndrome. Lancet (1991) 2.26

Diagnosis of coeliac disease: time for a change? Arch Dis Child (1989) 1.76

Postpubertal gluten challenge in coeliac disease. Arch Dis Child (1989) 1.55

A reliable screening test for childhood celiac disease: fluorescent immunosorbent test for gliadin antibodies. A prospective multicenter study. J Pediatr (1983) 1.29

Antibodies to gliadin detected by immunofluorescence and a micro-ELISA method: markers of active childhood and adult coeliac disease. Gut (1985) 1.28

Immune response patterns in coeliac disease. Serum antibodies to dietary antigens measured by an enzyme linked immunosorbent assay (ELISA). Clin Exp Immunol (1984) 1.25

Anti-gliadin antibodies. J Pediatr Gastroenterol Nutr (1991) 1.23

Binding to human jejunum of serum IgA antibody from children with coeliac disease. Lancet (1990) 1.22

Relationship of endomysial antibodies to jejunal mucosal pathology: specificity towards both symptomatic and asymptomatic celiacs. J Pediatr Gastroenterol Nutr (1989) 1.15

Gluten-sensitive enteropathy in childhood. Pediatr Clin North Am (1988) 1.14

IgG, IgA and IgE gliadin antibody determinations as screening test for untreated coeliac disease in children, a multicentre study. Eur J Pediatr (1989) 1.11

Humoral response to alpha gliadin as serological screening test for coeliac disease. Arch Dis Child (1987) 0.97

Changes of serum antibody activities to various dietary antigens related to gluten withdrawal or challenge in children with coeliac disease. Int Arch Allergy Appl Immunol (1985) 0.96

Antibodies to gliadin as a screening test for coeliac disease. A prospective study. Helv Paediatr Acta (1979) 0.95

Immunofluorescent antibodies against gliadin: a screening test for coeliac disease. Helv Paediatr Acta (1976) 0.94

Gliadin-specific serum immunoglobulins A, E, G, and M in childhood: relation to small intestine mucosal morphology. J Pediatr Gastroenterol Nutr (1985) 0.90

IgA antigliadin antibodies in celiac and inflammatory bowel disease. J Pediatr Gastroenterol Nutr (1984) 0.90

IgG endomysial antibodies in IgA-deficient patient with coeliac disease. Lancet (1989) 0.90

Serum gliadin antibodies for detection and control of childhood coeliac disease. Acta Paediatr Scand (1984) 0.88

Gluten IgA antibodies and coeliac disease. Lancet (1989) 0.86

Serum IgG antibodies to gliadin in children with celiac disease as measured by an immunofluorescence method. J Pediatr Gastroenterol Nutr (1984) 0.82

Serum antibodies to gliadin and other cereal proteins in patients with coeliac disease and dermatitis herpetiformis. Dan Med Bull (1985) 0.81

A rapid fluorescent solid-phase method for detecting antibodies against milk proteins and gliadin in different immunoglobulin classes. Experientia (1972) 0.80

A solid-phase radioimmunoassay for IgG gliadin antibodies using 125I-labelled staphylococcal protein A. J Immunol Methods (1983) 0.80

Articles by these authors

Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G. Science (1968) 7.70

Receptor sites for complement on certain human peripheral blood lymphocytes. J Immunol (1970) 4.09

Receptor sites of human monocytes for IgG. Int Arch Allergy Appl Immunol (1968) 4.07

Ascent of dinosaurs linked to an iridium anomaly at the Triassic-Jurassic boundary. Science (2002) 3.69

Crystal structure of the thermosome, the archaeal chaperonin and homolog of CCT. Cell (1998) 2.94

Laminin, a multidomain protein. The A chain has a unique globular domain and homology with the basement membrane proteoglycan and the laminin B chains. J Biol Chem (1988) 2.74

Taxonomic relations between archaebacteria including 6 novel genera examined by cross hybridization of DNAs and 16S rRNAs. J Mol Evol (1982) 2.64

The IgG receptor: an immunological marker for the characterization of mononuclear cells. Immunology (1969) 2.46

Interleukin-6 is a prognostic factor in multiple myeloma. Blood (1991) 2.16

Cortical scintigraphy in the evaluation of renal parenchymal changes in children with pyelonephritis. J Pediatr (1994) 2.15

Ferroglobus placidus gen. nov., sp. nov., A novel hyperthermophilic archaeum that oxidizes Fe2+ at neutral pH under anoxic conditions. Arch Microbiol (1996) 2.06

Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood (1992) 2.05

Operation for N2 small cell lung carcinoma. Ann Thorac Surg (1990) 2.04

Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy. Pediatr Infect Dis (1987) 1.92

Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy. Blood (1998) 1.90

Presence of acetyl coenzyme A (CoA) carboxylase and propionyl-CoA carboxylase in autotrophic Crenarchaeota and indication for operation of a 3-hydroxypropionate cycle in autotrophic carbon fixation. J Bacteriol (1999) 1.86

The interaction of monocytes and macrophages with immunoglobulins and complement. Ser Haematol (1970) 1.82

In vitro reactivity of human lymphocytes in uraemia--a comparison with the impairment of delayed hypersensitivity. Clin Exp Immunol (1969) 1.73

Respiration of arsenate and selenate by hyperthermophilic archaea. Syst Appl Microbiol (2000) 1.70

Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Blood (2000) 1.64

Reclassification of the crenarchael orders and families in accordance with 16S rRNA sequence data. Int J Syst Bacteriol (1997) 1.63

A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. Oncogene (2006) 1.62

Urinary 5-hydroxyindoleacetic acid in 8-hour collections as an aid in diagnosis of coeliac disease. Arch Dis Child (1975) 1.55

Inhibition of capillary migration by antigen-antibody complexes. J Immunol (1969) 1.55

IgG subclass specificity of human monocyte receptor sites. Nature (1971) 1.55

Cisapride reduces postoperative gastrocaecal transit time after cardiac surgery in children. Intensive Care Med (1996) 1.50

Organic solutes in hyperthermophilic archaea. Appl Environ Microbiol (1997) 1.49

PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression. Oncogene (2006) 1.48

A defect in circulating mononuclear phagocytes in chronicgranulomatous disease of childhood. J Immunol (1968) 1.44

Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene (2009) 1.43

Towards the ecology of hyperthermophiles: biotopes, new isolation strategies and novel metabolic properties. FEMS Microbiol Rev (2000) 1.42

Nitric oxide induces apoptosis in mouse thymocytes. J Immunol (1995) 1.40

Detection of flexor tenosynovitis by magnetic resonance imaging: its relationship to diurnal variation of symptoms. J Rheumatol (1991) 1.40

Biosynthesis and maturation of lactase-phlorizin hydrolase in the human small intestinal epithelial cells. Biochem J (1987) 1.39

Antibodies against human tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease. Scand J Gastroenterol (2002) 1.38

Non-pancreatic hydrolysis of N-benzoyl-l-tyrosyl-p-aminobenzoic acid (PABA-peptide) in the human small intestine. Clin Sci (Lond) (1982) 1.37

Surgical correction of cryptorchism at 2 years: electron microscopic and morphometric investigations. J Pediatr Surg (1975) 1.36

Thiobacillus ferrooxidans, a facultative hydrogen oxidizer. Appl Environ Microbiol (1990) 1.30

The PRIPS study: screening battery for subjects at risk for Parkinson's disease. Eur J Neurol (2012) 1.29

A reliable screening test for childhood celiac disease: fluorescent immunosorbent test for gliadin antibodies. A prospective multicenter study. J Pediatr (1983) 1.29

Receptor sites on human monocytes for complement: binding of red cells sensitized by cold autoantibodies. Br J Haematol (1970) 1.23

Abnormal biliary lipid composition in cystic fibrosis. Effect of pancreatic enzymes. N Engl J Med (1977) 1.23

Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut (2003) 1.23

ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression. Oncogene (2008) 1.21

In vivo observation of cell division of anaerobic hyperthermophiles by using a high-intensity dark-field microscope. J Bacteriol (1999) 1.20

The impact of hemoglobin levels on fatigue and quality of life in cancer patients. Ann Oncol (2002) 1.20

Immunocytochemical demonstration of ecto-galactosyltransferase in absorptive intestinal cells. J Cell Biol (1985) 1.17

Lipopolysaccharide modulation of normal enterocyte turnover by toll-like receptors is mediated by endogenously produced tumour necrosis factor alpha. Gut (2002) 1.15

The importance of both an early orchidopexy and germ cell maturation for fertility. Lancet (2001) 1.12

Classification of complications after progressive long bone lengthening: proposal for a new classification. Orthop Traumatol Surg Res (2012) 1.12

Electron microscopic studies of human monocyte and lymphocyte interaction with immunoglobulin- and complement-coated erythrocytes. Exp Cell Res (1972) 1.11

Long-term cimetidine in children with cystic fibrosis: a randomized double-blind study. Pediatr Res (1984) 1.11

N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase: a metalloendopeptidase of the human intestinal microvillus membrane which degrades biologically active peptides. Arch Biochem Biophys (1988) 1.11

Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. Blood (1996) 1.11

IgG, IgA and IgE gliadin antibody determinations as screening test for untreated coeliac disease in children, a multicentre study. Eur J Pediatr (1989) 1.11

The agglutinating antibody response in the duodenum in infants with enteropathic E. coli gastroenteritis. Gut (1975) 1.10

Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunol (2008) 1.09

Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis. Gut (1990) 1.09

Buserelin treatment of cryptorchidism: a randomized, double-blind, placebo-controlled study. J Urol (1992) 1.07

[The blood-xylose test in childhood: correlation between 1 hour blood-xylose levels and numbers of intraepithelial lymphocytes in intestinal mucosa in celiac disease]. Helv Paediatr Acta (1976) 1.07

Nuclear magnetic resonance spectroscopy. Carbon-13 spin-lattice relaxation time measurements of amino acids. Proc Natl Acad Sci U S A (1974) 1.07

Molecular signatures and new candidates to target the pathogenesis of rheumatoid arthritis. Physiol Genomics (2010) 1.07

Nucleoid structure and partition in Methanococcus jannaschii: an archaeon with multiple copies of the chromosome. Genetics (1999) 1.06

Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer. Br J Cancer (1995) 1.06

The Zurich Study: participation patterns and Symptom Checklist 90-R scores in six interviews, 1979-99. Acta Psychiatr Scand Suppl (2003) 1.05

Prodromal features for Parkinson's disease--baseline data from the TREND study. Eur J Neurol (2014) 1.03

Relation between occupational asthma case history, bronchial methacholine challenge, and specific challenge test in patients with suspected occupational asthma. Am J Ind Med (1998) 1.02

Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parameters. Ann Hematol (1991) 1.02

Unilateral fixed dilated pupil in an infant after inhalation of nebulized ipratropium bromide. J Pediatr (2000) 1.02

An SH3 domain is required for the mitogenic activity of microinjected phospholipase C-gamma 1. FEBS Lett (1995) 1.02

Two-step approach for diagnosing celiac disease. Clin Gastroenterol Hepatol (2008) 1.01

Biosynthesis of the human sucrase-isomaltase complex. Differential O-glycosylation of the sucrase subunit correlates with its position within the enzyme complex. J Biol Chem (1988) 1.01

Biogenesis of intestinal lactase-phlorizin hydrolase in adults with lactose intolerance. Evidence for reduced biosynthesis and slowed-down maturation in enterocytes. J Clin Invest (1990) 1.01

Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells. Cancer Res (2000) 1.00

Histologic maldevelopment of unilaterally cryptorchid testes and their descended partners. Eur J Pediatr (1993) 1.00

Transport to cell surface of intestinal sucrase-isomaltase is blocked in the Golgi apparatus in a patient with congenital sucrase-isomaltase deficiency. Proc Natl Acad Sci U S A (1985) 1.00

Diminished contact hypersensitivity response in IL-4 deficient mice at a late phase of the elicitation reaction. Scand J Immunol (1997) 0.98

The effect of anti-lymphocyte globulin on human monocytes in vitro. Clin Exp Immunol (1969) 0.98

Expression of the neural cell adhesion molecule (CD56) by human myeloma cells. Clin Exp Immunol (1991) 0.98

Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood (1995) 0.98

Purification and properties of an extremely thermostable membrane-bound sulfur-reducing complex from the hyperthermophilic Pyrodictium abyssi. Eur J Biochem (1998) 0.97

Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease. Gut (2004) 0.97

[Properties and subcellular localization of newly synthesized proteins of human lymphocytes in vitro with and without the addition of phytohemagglutinin]. Klin Wochenschr (1967) 0.96

Retinoic acid induced death of ovarian carcinoma cells correlates with c-myc stimulation. Int J Cancer (1995) 0.96

Functional impairment of lymphocytes and monocytes: assessment in vitro. Semin Hematol (1971) 0.96

Cystic fibrosis in 3 Pakistani children. Arch Dis Child (1974) 0.95

Fluoride released from orthodontic bonding agents alters the enamel surface and inhibits enamel demineralization in vitro. Am J Orthod Dentofacial Orthop (1996) 0.95

Receptor sites for aggregated gammaglobulin (AGG) on lymphocytes in lymphoproliferative diseases. Br J Haematol (1974) 0.94

Value of 1-hour blood-xylose test in diagnosis of childhood coeliac disease. Arch Dis Child (1978) 0.94

Susceptibility to FAS-induced apoptosis in human nontumoral enterocytes: role of costimulatory factors. J Cell Physiol (1999) 0.94

Structure, biosynthesis, and glycosylation of human small intestinal maltase-glucoamylase. J Biol Chem (1988) 0.94

Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer. Breast Cancer Res Treat (1998) 0.94

Screening test for coeliac disease. Lancet (1997) 0.93

The bacteriophage P1 site-specific recombinase cin: recombination events and DNA recognition sequences. Cold Spring Harb Symp Quant Biol (1984) 0.93

Malignant cell detection by fluorescence in situ hybridization (FISH) in effusions from patients with carcinoma. Hum Pathol (2000) 0.93

Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123. Br J Haematol (1992) 0.93